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he concept of the plasticity or transdifferentiation of
adult stem cells has been challenged by the phe-
nomenon of cell fusion. In this work, we examined
whether neonatal cardiomyocytes fuse with various so-
matic cells including endothelial cells, cardiac ﬁbroblasts,
bone marrow cells, and endothelial progenitor cells spon-
taneously in vitro. When cardiomyocytes were cocultured
with endothelial cells or cardiac ﬁbroblasts, they fused
and showed phenotypes of cardiomyocytes. Furthermore,
T
 
cardiomyocytes reentered the G2-M phase in the cell
cycle after fusing with proliferative noncardiomyocytes.
Transplanted endothelial cells or skeletal muscle–derived
cells fused with adult cardiomyocytes in vivo. In the cryo-
injured heart, there were Ki67-positive cells that ex-
pressed both cardiac and endothelial lineage marker
proteins. These results suggest that cardiomyocytes fuse
with other cells and enter the cell cycle by maintaining
their phenotypes.
 
Introduction
 
Many reports have indicated that adult stem cells have “plas-
ticity” and transdifferentiate into various types of cells includ-
ing cardiomyocytes (Jackson et al., 2001; Orlic et al., 2001a;
Badorff et al., 2003). Bone marrow cells have been incorpo-
rated into the damaged myocardium and have expressed car-
diac-specific proteins (Jackson et al., 2001; Orlic et al., 2001a;
Mangi et al., 2003). Besides undifferentiated stem cells, differen-
tiated somatic cells such as endothelial cells and skeletal mus-
cle–derived cells have been also reported to transdifferenti-
ate into cardiomyocytes when cocultured with cardiomyocytes
(Condorelli et al., 2001; Iijima et al., 2003). However, the con-
cept of plasticity has been challenged by the new findings that
embryonic stem cells adopt the phenotype of bone marrow
cells or central nervous stem cells by cell fusion (Terada et al.,
2002; Ying et al., 2002). Bone marrow cells have been re-
ported to fuse with hepatocytes in the severely injured liver
and proliferate extensively, resulting in millions of highly an-
euploid new hepatocytes (Vassilopoulos et al., 2003; Wang et
al., 2003). In the brain, bone marrow cells form stable hetero-
karyons with Purkinje neurons in the absence of selective
pressure. In this intracellular milieu, bone marrow cell–derived
nuclei are reprogrammed to activate the Purkinje-specific
gene, resulting in the phenotype of the Purkinje cells becoming
dominant over time (Weimann et al., 2003). These results sug-
gest that cell fusion might be one of the physiological mecha-
nisms through which the cells change their lineage and the
tissues are rejuvenated or regenerated.
Adult cardiomyocytes have been thought to be terminally
differentiated and unable to divide, thus myocyte growth under
pathologic conditions as well as physiologic conditions is be-
lieved to be accomplished only by cellular hypertrophy (Mor-
gan and Baker, 1991; Chien, 1995). Cytoplasmic extracts of
adult cardiomyocytes have been reported to reduce the expres-
sion of proliferating cell nuclear antigens in proliferating non-
cardiomyocytes (Engel et al., 2003), suggesting that some
inhibitory molecules of the cell cycle might exist in the cyto-
plasm of adult cardiomyocytes. However, recent reports have
indicated that adult cardiomyocytes can divide after myocar-
dial infarction and at end-stage heart failure (Kajstura et al.,
1998; Beltrami et al., 2001). The precise mechanism of how
cardiomyocytes acquire proliferative ability is still elusive, but
there is a possibility that mobilized bone marrow–derived stem
cells or cardiac progenitor cells start to proliferate in response
to some environmental cues (Orlic et al., 2001b; Beltrami et al.,
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2003; Matsuura et al., 2004). Recently, Oh et al. (2003) have
reported that transplanted cardiac progenitor cells in the adult
murine heart not only differentiate into cardiomyocytes, but
also fuse with preexisting cardiomyocytes in the ischemia
model. This finding indicates that there is another possible ex-
planation, in which the ability to proliferate might be conferred
on cardiomyocytes by surrounding proliferative noncardio-
myocytes by means of cell fusion in the diseased heart. To
date, two studies have been reported regarding the cell fusion
between cardiomyocytes and noncardiomyocytes. Evans et al.
Figure 1. HUVEC and cFB acquired the cardiac phenotype through cell fusion with cardiomyocytes. (A) LacZ-expressing cardiomyocytes of neonatal rats
were cocultured with GFP
  HUVEC (a–d) or GFP
  cFB (e–h) and stained with mouse monoclonal anti-cTnT (red) and rabbit polyclonal anti- -gal antibodies
(blue). Merged images were obtained from the same confocal plane. GFP
  HUVEC and GFP
  cFB (a and e, arrow) expressed cTnT (b and f, arrow) and
 -gal (c and g, arrow) in the same cell (merged on d and h). Arrowheads indicate the nonfused cardiomyocytes. Bars, 50  m. (B) LacZ-expressing cardio-
myocytes of neonatal rats were cocultured with GFP
  HUVEC (a–f) or GFP
  cFB (g–l) and stained with mouse monoclonal anti-cTnT (red) and goat poly-
clonal anti-GATA4 or rabbit polyclonal anti-ANF or anti-connexin43 antibodies (blue). cTnT-expressing GFP
  HUVEC (a, c, and e) and cTnT-expressing
GFP
  cFB (g, i, and k) expressed GATA4 (b and h, arrowhead), ANF (d and j, arrowhead), and connexin43 (f and l, arrowhead). Bars, 50  m. 
CARDIOMYOCYTES FUSE WITH VARIOUS CELLS • MATSUURA ET AL.
 
353
 
(1994) have reported that neonatal cardiomyocytes lose their
cardiac phenotypes when forced to fuse with embryonic fibro-
blasts by using polyethylene glycol. Alvarez-Dolado et al.
(2003) have demonstrated that transplanted bone marrow cells
fuse with cardiac myocytes in the heart and express cardiac
contractile proteins. Currently, it is still unknown which of the
mechanisms, transdifferentiation or fusion, plays a major role
in phenotypic change of the cells in the heart. Therefore, it is
important to examine the fusiogenic ability of cardiomyocytes
with various types of cells in vivo and in vitro and to know
Figure 2. HUVEC and cFB acquired the cardiac phenotype through cell fusion with cardiomyocytes. (A) Cardiomyocytes of GFP transgenic neonatal rats
were cocultured with RFP
  HUVEC (a–d) and RFP
  cFB (e–h) and were stained with mouse monoclonal anti-cTnT (blue). Merged images were obtained
from the same confocal plane. RFP
  HUVEC and RFP
  cFB (b and f, arrow) expressed cardiomyocyte-derived GFP (a and e, arrow) and cTnT (c and g,
arrow) in the same cell (merged on d and h). Arrowheads indicate GFP
  noncardiomyocyte. Bars, 50  m. (B) Cardiomyocytes of GFP transgenic neonatal
rats were cocultured with RFP
  HUVEC (a–f) and RFP1 cFB (g–l) and were stained with goat polyclonal anti-GATA4 or rabbit polyclonal anti-ANF, anti-
vWF, or mouse monoclonal anti-vimentin antibodies (blue). GFP
 /RFP
  cardiomyocyte-HUVEC fused cells (a and c) and GFP
 /RFP
  cardiomyocyte-cFB
fused cells (g and i) expressed GATA4 (b and h, arrowhead) and ANF (d and j, arrowhead). GFP
 /RFP
  cardiomyocyte-HUVEC fused cells (e) express
vWF (f, arrowhead) and GFP
 /RFP
  cardiomyocyte-cFB fused cells (k) express vimentin (l, arrowhead). Bars, 50  m. 
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whether cardiomyocytes can obtain proliferative ability after
fusion without losing cardiac phenotypes.
Here, we demonstrate that neonatal cardiomyocytes fuse
with various kinds of somatic cells including human umbilical
vein endothelial cells (HUVEC), cardiac fibroblasts (cFB),
bone marrow cells, and endothelial progenitor cells (EPCs)
spontaneously in vitro. When cardiomyocytes fused with HU-
VEC or cFB both phenotypes were observed at first, but car-
diac phenotypes became dominant over time. Furthermore,
terminally differentiated cardiomyocytes reentered the G2-M
phase in the cell cycle after cell fusion with proliferative non-
cardiomyocytes. Cardiomyocytes spontaneously fused with
transplanted HUVEC and skeletal muscle–derived cells in
vivo and maintained the phenotypes of cardiomyocytes. Fi-
nally, we demonstrated that some cells in the cryoinjured
heart expressed both cardiac and endothelial lineage marker
proteins along with Ki67.
 
Results
 
HUVEC and cFB acquired the cardiac 
phenotype through cell fusion with 
cardiomyocytes
 
When GFP-expressing (GFP
 
 
 
) HUVEC or GFP
 
 
 
 cFB were co-
cultured with neonatal rat cardiomyocytes that were infected
with the adenoviral vector carrying the 
 
LacZ
 
 reporter gene,
some of GFP
 
 
 
 HUVEC and GFP
 
 
 
 cFB coexpressed both car-
diac troponin T (cTnT) and 
 
 
 
-galactosidase (
 
 
 
-gal) (Fig. 1 A,
a–h, arrows). These GFP- and cTnT-expressing cells also ex-
pressed GATA4 (Fig. 1 B, a, b, g, and h, arrowheads), atrial
natriuretic factor (ANF) (Fig. 1 B, c, d, i and j, arrowheads), and
connexin43 (Fig. 1 B, e, f, k, and l, arrowheads). The expres-
sion of the cardiac proteins in GFP
 
 
 
 cells was observed only in
the coculture condition and all of cTnT-expressing HUVEC and
cFB were positive for 
 
 
 
-gal, suggesting that HUVEC and
cFB acquired the cardiac phenotype through cell fusion with
cardiomyocytes. The cTnT-positive GFP-expressing cells were
found in 0.019% of GFP
 
 
 
 HUVEC and 0.004% of GFP
 
 
 
 cFB
after 4 d of coculture. To rule out the possibility that noncar-
diomyocytes were infected with the adenoviral vector carrying
the 
 
LacZ
 
 reporter gene during coculture, we examined the cell
fusion by using neonatal cardiomyocytes prepared from GFP
transgenic rats and red fluorescent protein-expressing (RFP
 
 
 
)
HUVEC or RFP
 
 
 
 cFB. When RFP
 
 
 
 HUVEC or RFP
 
 
 
 cFB
were cocultured with GFP
 
 
 
 cardiomyocytes, some of RFP
 
 
 
HUVEC and RFP
 
 
 
 cFB coexpressed cardiomyocyte-derived
GFP and cTnT (Fig. 2 A, a–h, arrows). Some of both GFP- and
RFP-expressing (GFP
 
 
 
/RFP
 
 
 
) fused cells expressed GATA4
(Fig. 2 B, a, b, g, and h, arrowheads), ANF (Fig. 2 B, c, d, i, and
j, arrowheads), and connexin43 (unpublished data). Live imag-
ing showed that GFP
 
 
 
 cardiomyocytes fused with RFP
 
 
 
 HU-
VEC beat spontaneously (see Fig. S1 and Video 1, available at
http://www.jcb.org/cgi/content/full/jcb.200312111/DC1). They
beat regularly and the beating rate was 
 
 
 
80 beats/min, which
was similar to that of cocultured cardiomyocytes, suggesting
that cardiomyocyte function was maintained even after fusing
with other cells.
 
Cardiac phenotypes became predominant 
in fused cells
 
The von Willebrand factor (vWF) and vimentin are phenotype-
specific markers of endothelial cells and fibroblasts, respec-
tively, and are never expressed in cardiomyocytes. When GFP
 
 
 
cardiomyocytes were cocultured with RFP
 
 
 
 HUVEC or RFP
 
 
Figure 3. Cardiac phenotype is dominated in
fused cells. (A and B) Each bar represents the
number of GFP
 /RFP
  fused cells in 10
5 RFP
 
HUVEC cocultured with GFP
  neonatal rat
cardiomyocytes at different time in culture.
The number of GFP
 /RFP
  fused cells was in-
creased with the time-dependent manner. The
percentage of cTnT-positive cells and the per-
centage of vWF-positive cells in GFP
 /RFP
 
fused cells are presented by line graphs. The
percentage of cTnT-positive cells in GFP
 /
RFP
  fused cells (A) increased and that of
vWF-positive cells (B) decreased with the time-
dependent manner. Data are mean   SD of
three independent experiments. *, P   0.01
vs. 1 d; 
†, P   0.01 vs. 4 d; 
‡, P   0.05 vs.
1 d. (C and D) Each bar represents the num-
ber of GFP
 /RFP
  fused cells in 10
5 RFP
  cFB
cocultured with GFP
  neonatal rat cardiomyo-
cytes at different time in culture. The number of
GFP
 /RFP
  fused cells was increased with the
time-dependent manner. The percentage of
cTnT-positive cells and the percentage of vi-
mentin-positive cells in GFP
 /RFP
  fused cells
are presented by line graphs. The percentage
of cTnT-positive cells in GFP
 /RFP
  fused cells
(C) increased and that of vimentin-positive
cells (D) decreased with the time-dependent
manner. Data are mean   SD of three inde-
pendent experiments. *, P   0.01 vs. 1 d; 
†,
P   0.01 vs. 4 d; 
‡, P   0.05 vs. 1 d. 
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cFB, some of GFP
 
 
 
/RFP
 
 
 
 fused cells expressed vWF (Fig. 2
B, e and f) and vimentin (Fig. 2 B, k and l), respectively. To
elucidate the phenotype in fused cells, we quantified the per-
centage of cTnT-, vWF-, or vimentin-expressing cells in the
GFP
 
 
 
/RFP
 
 
 
 fused cells. When GFP
 
 
 
 cardiomyocytes were co-
cultured with RFP
 
 
 
 HUVEC, the number of GFP
 
 
 
/RFP
 
 
 
 fused
cells was increased with the time-dependent manner (Fig. 3, A
and B, bar graphs; Table I). The percentage of cTnT-express-
ing cells in the total fused cells was also increased with the
time-dependent manner (d 1, 58.6 
 
 
 
 2.9%; d 4, 73.7 
 
 
 
 3.9%; d
7, 76.2 
 
 
 
 1.9%); on the other hand, the percentage of vWF-
expressing cells in fused cells was decreased with the time-
dependent manner (d 1, 41.3 
 
 
 
 10.3%; d 4, 39.2 
 
 
 
 3.7%; d 7,
27.7 
 
 
 
 1.6%), suggesting that the cardiac phenotype becomes
predominant in the cells formed by fusion between cardiomyo-
cytes and endothelial cells (Fig. 3, A and B, line graphs; Table
I). When GFP
 
 
 
 cardiomyocytes were cocultured with RFP
 
 
 
cFB, the number of GFP
 /RFP
  fused cells was gradually in-
creased (Fig. 3, C and D, bar graphs; Table II). The percentage
of cTnT-expressing cells in fused cells was also increased with
the time-dependent manner (d 1, 54.2   3.8%; d 4, 75.8  
5.6%; d 7, 83.5   2.6%); on the other hand, the percentage of
vimentin-expressing cells (Fig. 2 B, k and l) in fused cells was
decreased progressively (d 1, 45.3   9.3%; d 4, 25.9   8.8%; d
7, 11.5   1.6%), suggesting that cardiac phenotypes also dom-
inate in fused cells between cardiomyocytes and cFB (Fig. 3, C
and D, line graphs; Table II).
Cardiomyocytes reenter the cell cycle by 
cell fusion with adult somatic cells in 
vitro
To determine whether cardiomyocytes reenter the cell cycle af-
ter fusion, we examined the expression of the cell cycle marker
proteins such as Ki67, phosphohistone H3 (PH3), and cyclinB1
in fused cells. First, we examined whether monocultured HU-
VEC, cFB, and neonatal cardiomyocytes expressed Ki67, PH3,
and cyclinB1 (Fig. 4). Many of HUVEC and cFB in the growth
medium expressed Ki67, PH3, and cyclinB1 in their nuclei.
Some neonatal rat cardiomyocytes expressed Ki67, but not
PH3 and cyclinB1, suggesting that some neonatal cardiomyo-
cytes are in the G1-S stage, but not in the G2-M stage of the
cell cycle. However, when fused with HUVEC and cFB some
cardiomyocytes expressed PH3 (Fig. 5 b for HUVEC and Fig.
5 d for cFB) and cyclinB1 (Fig. 5 f for HUVEC and Fig. 5 h for
cFB). Among cardiomyocytes fused with HUVEC,  9% of the
cells expressed PH3 (Fig. 6 A). When treated for 6 h with no-
codazole, an inhibitor of microtubule dynamics and cell cycle
progression (Blajeski et al., 2002; Tamamori-Adachi et al.,
2003), the number of PH3-expressing fused cells was increased
up to  21% in fused cells. At 3 h after the withdrawal of no-
codazole, this number was decreased to  15%. In cardiomyo-
cytes fused with cFB (Fig. 6 B),  14% of the cells expressed
PH3, and at 24 h after the nocodazole treatment the number of
PH3-expressing fused cells was increased up to  29%. This
number was decreased to  20% at 3 h after the withdrawal of
Table II. The phenotypic analysis of fused cells between cardiomyocytes and cardiac fibroblasts
Number of cells in 10
5 RFP
  cardiac fibroblasts (% of total fused cells)
1 d 4 d 7 d
GFP
 /RFP
 /TnT
  1.29   0.19 (54.2%) 3.19   0.20 (75.8%) 4.31   0.33 (83.5%)
c
GFP
 /RFP
 /TnT
  1.08   0.17 (45.8%) 1.02   0.16 (24.2%) 0.86   0.23 (16.5%)
c
GFP
 /RFP
  2.37   0.31 4.21   0.11
a 5.17   0.54
a,b
GFP
 /RFP
 /Vimentin
  1.28   0.49 (45.3%) 1.12   0.35 (25.9%) 0.59   0.06 (11.5%)
c
GFP
 /RFP
 /Vimentin
  1.46   0.25 (54.7%) 3.13   0.20 (74.1%) 4.59   0.15 (88.5%)
c
GFP
 /RFP
  2.74   0.60 4.25   0.37
a 5.18   0.14
a,b
Times indicate period after starting coculture. Fused cells were detected as GFP
 /RFP
  cells. Each number represents the number of cells in 10
5 RFP
  cardiac fibroblasts.
Data are mean   SD of three independent experiments.
aP   0.01 vs. 1 d.
bP   0.01 vs. 4 d.
cP   0.05 vs. 1 d.
Table I. The phenotypic analysis of fused cells between cardiomyocytes and HUVEC
Number of cells in 10
5 RFP
  HUVEC (% of total fused cells)
1 d 4 d 7 d
GFP
 /RFP
 /TnT
  3.86   0.64 (58.6%) 27.2   4.0 (73.7%) 44.2   0.7 (76.2%)
c
GFP
 /RFP
 /TnT
  2.72   0.26 (41.4%) 9.7   0.9 (26.3%) 13.8   1.2 (23.8%)
c
GFP
 /RFP
  6.59   0.89 36.9   3.2
a 58.0   1.9
a,b
GFP
 /RFP
 /VW
  2.79   0.93 (41.3%) 13.5   1.8 (39.2%) 17.4   1.6 (27.7%)
c
GFP
 /RFP
 /VW
  3.71   0.32 (58.7%) 20.7   0.6 (60.8%) 45.2   4.2 (72.3%)
c
GFP
 /RFP
  6.49   1.17 34.2   3.6
a 62.6   5.9
a,b
Times indicate period after starting coculture. Fused cells were detected as GFP
 /RFP
  cells. Each number represents the number of cells in 10
5 RFP
  HUVEC.
Data are mean   SD of three independent experiments.
aP   0.01 vs. 1 d.
bP   0.01 vs. 4 d.
cP   0.05 vs. 1 d.JCB • VOLUME 167 • NUMBER 2 • 2004 356
nocodazole. These results suggest that some cardiomyocytes
reenter the stage of mitosis after fusion with HUVEC and cFB.
Mitosis of fused cardiomyocytes was confirmed by the exist-
ence of cells that showed visible chromosomes characteristic of
the several distinct phases of mitosis (Fig. 6 C). In Fig. 6, GFP
 
cardiomyocytes fused with RFP
  HUVEC (b and j) or RFP
 
cFB (f) show prophase chromosomes (c), metaphase chromo-
somes (g), and anaphase chromosomes (k).
Cardiomyocytes spontaneously fuse with 
surrounding somatic cells in vivo
Next, we examined whether cardiomyocytes fuse with other
mature somatic cells in vivo as well as in vitro. RFP
  HUVEC
or RFP
  skeletal muscle–derived cells isolated from neonatal
Sprague-Dawley rats were first injected into the hearts of adult
GFP transgenic Sprague-Dawley rats. At 7 d after injection, we
observed GFP and RFP double-positive cells, which also ex-
pressed cTnT, in the heart (Fig. 7 A). The expression of two
different kinds of dyes in the single cell suggests that spontane-
ous cell fusion could also occur in vivo in the heart. Further-
more, we examined the cell fusion in vivo by using the Cre/lox
recombination assay. HUVEC infected with adenovirus con-
taining the nuclear-localized Cre recombinase gene (Kanegae
et al., 1995) were transplanted directly to the heart of mice
that carry the loxP-flanked chloramphenicol acetyltransferase
(CAT) gene located between the CAG promoter and the LacZ
Figure 4. Localization of Ki67, PH3, and cyclinB1 in cFB, HUVEC, and neonatal cardiomyocytes. GFP
  cFB, GFP
  HUVEC, and neonatal rat cardiomyo-
cytes were stained with mouse monoclonal anti-Ki67 (top row, red), rabbit polyclonal anti-PH3 (middle row, red), and mouse monoclonal anti-cyclinB1
(bottom row, red). Cardiomyocytes were identified with anti-cTnT antibodies (blue). HUVEC and cFB expressed Ki67, PH3, and cyclinB1. Some of neona-
tal cardiomyocytes expressed Ki67, but not PH3 or cyclinB1. Bars, 50  m.
Figure 5. Neonatal rat cardiomyocytes ex-
pressed PH3 and cyclinB1 after cell fusion with
HUVEC or cFB. Neonatal rat cardiomyocytes
were cocultured with GFP
  HUVEC or GFP
 
cFB and double stained with anti-cTnT (red)
and anti-PH3 (blue) or anti-cyclinB1 (blue) an-
tibodies. Fused cells between cardiomyo-
cytes and HUVEC or cFB coexpressed both
GFP and cTnT (a, c, e, and g, yellow in
merged images), and expressed PH3 (b and
d, blue) and cyclinB1 (f and h, blue) in their
nuclei. Bars, 50  m.CARDIOMYOCYTES FUSE WITH VARIOUS CELLS • MATSUURA ET AL. 357
gene (Fig. 8 A, CAG-CAT-LacZ). At 4 d after transplantation,
some  -gal
  cells were observed in the myocardium, and the
same cells in the adjacent sections showed the expression of
Cre and cTnT with the fine striated pattern. A typical image
was presented in Fig. 8 B. Skeletal muscle–derived cells iso-
lated from CAG-CAT-LacZ mice were transplanted to the
heart of MerCreMer mice (Sohal et al., 2001) in which the ex-
pression of Cre was restricted to the cardiomyocytes under the
control of the  MHC promoter after treatment with tamoxifen
(Fig. 8 C). At 4 d after transplantation, we observed some
 -gal
  cells that coexpressed Cre and cTnT in the myocardium
(Fig. 8 D). These genetic results strongly suggest that HUVEC
and skeletal muscle–derived cells could fuse spontaneously
with cardiomyocytes in vivo. Next, we examined whether car-
diomyocytes spontaneously fuse with endogenous surrounding
cells in injured heart tissue. When adult rat hearts were cryoin-
jured there were cells expressing both cTnT and vWF at the
border zone, but not at the normal and injured areas (Fig. 7 B).
Staining of adjacent sections revealed that cells that expressed
both cTnT and vWF also expressed desmin and Ki67 (Fig. 7
B), whereas there were no Ki67-expressing cardiomyocytes in
the normal adult heart. These findings suggest that cardiomyo-
cytes fuse with surrounding endothelial lineage cells and reen-
ter the cell cycle also in vivo.
Bone marrow–derived cells and EPCs can 
fuse with cardiomyocytes in vitro
Our in vitro and in vivo results suggest that cells expressing
both cTnT and vWF in the damaged heart are fusion products
of cardiomyocytes and endothelial cells. However, it has been
reported that bone marrow–derived cells and EPCs differenti-
ate into vascular cells and cardiomyocytes (Jackson et al.,
2001; Badorff et al., 2003), leading us to examine whether
bone marrow–derived or peripheral blood–derived EPCs may
fuse with cardiomyocytes and express cTnT and vWF. He-
matopoietic cells and mesenchymal cells from bone marrow of
GFP transgenic mouse and human-derived EPCs were cocul-
tured with neonatal cardiomyocytes that were infected with the
adenoviral vector carrying the LacZ reporter gene. When GFP
 
bone marrow–derived mesenchymal cells were cocultured with
LacZ
  neonatal rat cardiomyocytes,  0.01% of GFP
  cells ex-
pressed cTnT and  -gal, suggesting that bone marrow–derived
mesenchymal cells express cardiac-specific protein through
cell fusion with cardiomyocytes (Fig. 9 A, a–d, arrow). In con-
Figure 6. Cardiomyocytes of neonatal rats reentered the
cell cycle through cell fusion with HUVEC or cFB in vitro.
(A and B) Quantitative analysis of the percentage of PH3-
expressing cardiomyocytes fused with HUVEC or cFB.
The percentage of PH3-expressing cardiomyocytes in all
fused cells with HUVEC (A) and cFB (B) was significantly
increased with the treatment with nocodazole, and was
decreased after the withdrawal of nocodazole. Data are
mean    SD of four independent experiments. *, P  
0.05 vs. pretreatment. (C) Fluorescent images of GFP
 
cardiomyocytes fused with RFP
  HUVEC (top and bottom
rows, a–d and i–l) or RFP
  cFB (middle row, e–h) stained
with Hoechst 33258 (blue). Typical prophase chromo-
some (c), metaphase chromosome (g), and anaphase
chromosome (k) were visualized by Hoechst staining.
Merged fluorescent images indicate that fused cells show
mitotic figures. Bars, 50  m.JCB • VOLUME 167 • NUMBER 2 • 2004 358
trast, GFP
  hematopoietic cells expressed neither cTnT nor
 -gal when cocultured with LacZ
  neonatal rat cardiomyocytes.
Next, we isolated human-derived EPCs from the healthy volun-
teers and cultured them as described previously (Kalka et al.,
2000). At 7 d after starting culture, spindle-shaped cells were
stained with DiI-AcLDL and FITC-labeled ulex europaeus ag-
glutinin-1 (UEA-1) lectin (Fig. 9 B, a and b), suggesting that
these adherent cells were endothelial lineage cells. Immunocy-
tochemical analysis revealed that  30% of these cells ex-
pressed vWF at this time (Fig. 9 B, c). When human-derived
EPCs were cocultured with neonatal mouse cardiomyocytes
that were infected with the adenoviral vector carrying the LacZ
reporter gene,  0.1% of vWF-expressing cells expressed cTnT
and  -gal (Fig. 9 C, a–d). Hoechst nuclear staining (Blau et al.,
1983) revealed that these cells contained both a human-derived
nucleus (smoothly appearance) and a mouse-derived nucleus
(punctate appearance) (Fig. 9 C, e–h), suggesting that human-
derived EPCs express cardiac-specific proteins through cell fu-
sion with cardiomyocytes. These results suggest that bone mar-
row–derived mesenchymal cells and circulating EPCs, but not
hematopoietic cells, fuse with cardiomyocytes.
Discussion
In this paper, we show that cardiomyocytes fuse with various
types of cells including endothelial cells, cFB, bone marrow–
derived mesenchymal cells, and EPCs in vitro. In the cells gen-
erated by fusion between cardiomyocytes and HUVEC or cFB,
the cardiac phenotype became dominant until at least 7 d after
starting coculture, and some fused cells reentered the cell cycle
maintaining the cardiac phenotype. Moreover, cardiomyocytes
fused with transplanted cells and surrounding cells in vivo as
well as in vitro.
Heterokaryons have been used to determine whether spe-
cific traits of either parental cells are maintained or extin-
guished (Baron, 1993; Blau and Blakely, 1999). In this work,
we identified fused cells retrovirally induced by two different
fluorescent dyes. Analysis of lineage-specific marker proteins
revealed that the phenotype of cardiomyocytes became more
dominant than that of HUVEC and cFB as time passed. Besides
the contractile proteins, a cardiac-specific secreted protein
(ANF) and a cardiac-selective transcription factor (GATA4)
were also expressed in the fused cells over 7 d. Moreover,
Figure 7. Adult cardiomyocytes fused with somatic cells in vivo. (A) RFP
  HUVEC or RFP
  skeletal muscle–derived cells were injected to the heart of GFP
transgenic rats, and 6- m sections were stained with rabbit polyclonal anti-RFP and mouse monoclonal anti-cTnT antibodies. Confocal microscopic images
demonstrate that GFP
  cardiomyocytes (a and g, green) coexpress RFP, marker proteins of HUVEC (b, red) and skeletal muscle–derived cells (h, red), and
cTnT (c and i, blue). d and j represent merged images; e and k represent phase-contrast images. The merged images of the same view were taken by
fluorescent microscope (f and l). Nuclei were stained with Hoechst 33258 (f and l, blue). Arrows indicate the fused cells. Bars, 100  m. (B) Two adjacent
sections of 6  m were cut from cryoinjured adult rat hearts. One section (a–d) was triple stained with mouse monoclonal anti-cTnT (red), rabbit polyclonal
anti-vWF (green) antibodies, and Topro3 (blue). Another section (e–h) was triple stained with rabbit polyclonal anti-desmin (red), mouse monoclonal anti-
Ki67 (green) antibodies, and Topro3 (blue). Confocal microscopic images in the border zone of cryoinjured hearts show a cell expressing vWF (a) and
cTnT (b) with nucleus stained by Topro3 (c). Right panel shows a same fine-striated cell that expresses desmin (f) and Ki67 (e) with nucleus stained by
Topro3 (g). d and h represent merged images. Bars, 100  m.CARDIOMYOCYTES FUSE WITH VARIOUS CELLS • MATSUURA ET AL. 359
fused cells not only expressed cardiac-specific proteins, but
also showed the function of cardiomyocytes (i.e., spontaneous
beating). Evans et al. (1994) have reported that neonatal car-
diomyocyte-fibroblast heterokaryons lose the expression of
myosin light chain 2 gene, ANF, and muscle enhancer factor 2
until 6 d, suggesting that the cardiac phenotype is recessive.
The discrepancy between our and Evans’s results may be ex-
plained by the difference in used cells and the method of cell
fusion. Evans et al. (1994) used embryonic fibroblasts for co-
culture and forced the inducing of cell fusion by using polyeth-
ylene glycol, whereas we used primary isolated cFB and ex-
amined the spontaneous fusion. It remains to be determined
whether the nuclei of noncardiomyocytes are reprogrammed to
express cardiac proteins by a dominantly acting cardiac factor.
An increase in cardiac mass during fetal period is accom-
plished predominantly by a cardiomyocyte proliferation, but
soon after birth there is a transition from hyperplastic to hyper-
trophic growth (Morgan and Baker, 1991; Chien, 1995). Many
studies have been made to elucidate the mechanism by which
cell cycle is arrested in postnatal cardiomyocytes (Agah et al.,
1997; Tamamori-Adachi et al., 2003). The adenoviral delivery
of cyclinD1 or E2F-1 has been reported to induce cardiomyo-
cytes to reenter the G2/M stage of the cell cycle. In the present
work, cardiomyocytes fused with noncardiomyocytes that have
proliferative ability expressed G2-M stage cell cycle proteins.
After the treatment with nocodazole, PH3-expressing fused cells
were significantly enriched, and after the withdrawal of nocoda-
zole, the number was decreased. Moreover, there were fused
cells showing the mitotic figures, suggesting that the cell cycle
was actively progressing toward the M stage in the fused cells.
Engel et al. (2003) have reported that p21 in the cytoplasm of
adult cardiomyocytes down-regulates the proliferating cell nu-
clear antigen protein level in S phase nuclei. The inhibitory ef-
fect of the adult cardiomyocyte extract was abolished when an
excess volume of S phase cytoplasmic extract from noncardio-
myocytes was present. In a similar way, the cytoplasmic factors
Figure 8. Cre/lox recombination assay for detection of
cell fusion in vivo. (A and C) Schematic representation of
the transgenes expressed by the mouse line and the ade-
novirus used in HUVEC transplantation model (A) and in
skeletal muscle–derived cell transplantation model (C). (B)
Cre-expressing HUVEC were transplanted to the heart of
CAG-CAT-LacZ mice. Two adjacent sections of 6  m
were prepared. One section treated with X-gal staining
demonstrated a  -gal
  cell in the myocardium (a and b,
arrow). The adjacent section, which was double stained
with mouse monoclonal anti-Cre and goat polyclonal
anti-cTnT antibodies, showed the expression of Cre (c,
green, arrow) and cTnT (c, red, arrow) with the fine-stri-
ated pattern in the same cell in a and b. Bars: a, 50  m;
b and c, 100  m. (D) Skeletal muscle–derived cells iso-
lated from CAG-CAT-LacZ mice were transplanted to the
heart of MerCreMer mice treated with tamoxifen. Sec-
tions were analyzed by X-gal staining or by triple staining
with rabbit polyclonal anti- -gal, goat polyclonal anti-
cTnT, and mouse monoclonal anti-Cre antibodies. X-gal
staining revealed a  -gal
  cell in the myocardium (a). The
immunofluorescent confocal images demonstrated that
 -gal
  (b and d, green) cells also expressed cTnT (c and
d, red) and Cre (c and d, blue). The merged images of
the same view of d were taken by fluorescent microscope
(e). Nuclei were stained with Hoechst 33258 (e, blue).
Arrows indicate the fused cells. Bars, 100  m.JCB • VOLUME 167 • NUMBER 2 • 2004 360
of the proliferative cells in the G2-M stage may overcome the
unknown endogenous cell cycle inhibitors in the heterokaryons.
We examined two kinds of cells for the in vivo transplan-
tation model. Endothelial cells are a component of the cardiac
interstitium, and it is possible that cardiomyocytes fuse with
surrounding endothelial cells. Skeletal muscle cells do not exist
in the myocardium, but myoblasts have the nature to fuse to
form myotubes (Tajbakhsh, 2003), and clinical trials of autol-
ogous skeletal myoblast transplantation into the failed heart
are currently underway (Menasche et al., 2003; Pagani et al.,
2003). Consistent with our in vitro results, cardiomyocytes
fused with transplanted HUVEC and skeletal muscle–derived
cells. Reinecke et al. (2002) have reported that skeletal myo-
blasts differentiate into mature skeletal muscle and do not ex-
press cardiac-specific genes after been grafted into the heart. In
their paper, rat satellite cells were tagged in vitro with BrdU,
and the grafted cells were examined by double staining with the
BrdU tag and cardiac-specific markers. However, this approach
would have disadvantage of potential signal dilution if there is
significant donor cell proliferation after transplantation (Dow-
ell et al., 2003). We used genetically modified animals and
cells that carry ubiquitously expressed fluorescent proteins or
that carry the Cre recombinase gene and the loxP-flanked CAT
gene located between CAG promoter and the LacZ gene for
monitoring donor cell fate after transplantation. These methods
possibly enabled us to find rare fused cells in the heart tissue.
In the cryoinjured heart model, some cells in the border
zone expressed both cardiomyocyte-specific and endothelial cell–
specific proteins. The images were taken with optical sections
through an appropriate confocal aperture, so that two different
lineage markers were exactly recognized in the same cells. When
we cocultured HUVEC with cardiomyocytes, some cells showed
transient coexpression of vWF with cardiac sarcomeric proteins
(unpublished data). Condorelli et al. (2001) have reported the
same findings as a phenomenon that demonstrates the transition
from one differentiated state (endothelium) to another (cardiac
muscle). Our findings that all cTnT-expressing HUVEC coex-
pressed cardiomyocyte-derived  -gal and that transplanted HU-
VEC and cardiomyocytes formed the hybrid cells in the myo-
cardium suggest that the cell fusion of cardiomyocytes with
Figure 9. Cardiomyocytes fused with adult immature
somatic cells in vitro. (A) LacZ-expressing cardiomyocytes
of neonatal rats were cocultured with GFP
  bone marrow
mesenchymal cells. After 4 d of coculture, cells were
stained with mouse monoclonal anti-cTnT (red) and rab-
bit polyclonal anti- -gal antibodies (blue). Merged im-
age was obtained from the same confocal plane. GFP
 
mesenchymal cells (a, arrow) expressed cTnT (b, arrow)
and  -gal (c, arrow) in the same cell (merged on d). Ar-
rowheads indicate bone marrow cells fused with noncar-
diomyocyte. Bars, 50  m. (B) Fluorescent microscopic
images of EPCs cultured 7 d after isolation from periph-
eral blood. EPCs were identified as double-positive cells
of DiI-labeled AcLDL uptake (a, red) and UEA-1 lectin re-
activity (b, yellow in merged images). Some adherent
cells expressed vWF (c, green). Nuclei were stained
with Hoechst 33258 (c, blue). Bars, 50  m. (C) Human-
derived EPCs were cocultured with neonatal mouse car-
diomyocytes infected with LacZ adenovirus. After 4 d of
coculture, cells were stained with rabbit polyclonal anti-
vWF (green), goat polyclonal anti-cTnT (red), and mouse
monoclonal anti- -gal antibodies (blue in top row) and
Hoechst 33258 (bottom row, blue). The fluorescent con-
focal microscopic images (a–d, top row) demonstrate that
vWF-expressing cells (a) expressed cTnT (b) and  -gal (c)
in the same cell. Note that Cy5-conjugated secondary an-
tibodies were used to visualize  -gal. The images of the
same cell were taken by fluorescent microscope (e–h,
bottom row). Hoechst staining of the nuclei revealed that
homogenously stained nuclei (arrow) were of human cell
origin and that mouse nuclei showed a punctate appear-
ance (arrowhead). d and h represent merged images.
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surrounding endothelial cells occurs in the damaged heart. How-
ever, we cannot exclude the possibility of the transdifferentiation
of endothelial cells into cardiomyocytes at present. Besides endo-
thelial cells, EPCs have been reported to transdifferentiate into
cardiomyocytes in an in vitro coculture model (Badorff et al.,
2003). Bone marrow cells have been reported to contain stem
cells, which transdifferentiate into various types of cells including
vascular cells and cardiomyocytes (Jackson et al., 2001; Orlic et
al., 2001a; Jiang et al., 2002). In our work, EPCs and bone mar-
row–derived mesenchymal cells expressed cardiac-specific pro-
teins through cell fusion with cocultured cardiomyocytes. There-
fore, it is possible that circulating EPCs or mesenchymal cells
may differentiate into endothelial cells and then fuse with car-
diomyocytes. Indeed, recent reports have suggested that trans-
planted bone marrow–derived cells fuse with preexisting he-
patocytes and cardiomyocytes (Alvarez-Dolado et al., 2003;
Vassilopoulos et al., 2003; Wang et al., 2003). Recently, cardiac
stem cells have been reported to exist in the adult heart (Beltrami
et al., 2003; Oh et al., 2003; Matsuura et al., 2004). Sca-1– or
c-kit–positive cells from the heart differentiate into cardiomyo-
cytes and other cells including endothelial cells in vitro. Oh et al.
(2003) have shown that intravenously infused Sca-1–positive car-
diac cells acquire the cardiac phenotypes by both transdifferentia-
tion and fusion, suggesting that cardiac stem cells may differenti-
ate into endothelial cells and then fuse with cardiomyocytes.
In the border zone of rat cryoinjured myocardium, some
cardiomyocytes that coexpressed both cTnT and vWF were
positively stained with anti-Ki67 antibodies. Ki67 is expressed
in all phases of the cell cycle except G0, becomes particularly
evident in the late S phase, and is increased further in the G2-M
phase. Although Ki67 is not a specific marker for the G2-M
stage, Beltrami et al. (2001) have concluded that cardiac myo-
cytes divide in the pathological condition by the evidence of
the Ki67 labeling of myocyte nuclei with the mitotic index. We
could not detect mitotic figures in the cells that were positively
stained with cTnT and vWF, but the expression of Ki67 was
observed only in the heterotypic fused cells. Because there
were no Ki67-positive nonfused cardiomyocytes, these results
suggest that the fused cells enter the cell cycle in vivo as well
as in vitro. Wagers and Weissman (2004) have proposed that
cell fusion–mediated regeneration might be considered a physi-
ological mechanism of repair. Our results suggest that aug-
mented cell fusion in the diseased heart may contribute to the
maintenance and replenishment of cardiomyocytes.
In conclusion, the present work demonstrates that car-
diomyocytes have the fusiogenic activity with many different
types of cells and obtain proliferative ability after fusion with
somatic cells without losing their phenotypes in vitro and in
vivo. Our future effort should be toward the understanding of
the molecular mechanisms of phenotypic determination and
cell cycle activation after fusion. During preparation of this
manuscript, Reinecke et al. (2004) have reported that skeletal
muscle cell grafting gives rise to skeletal–cardiac hybrid cells
with unknown phenotypes. Our findings from the thorough ex-
amination of the fused cells are relevant to today’s controversy
concerning cell plasticity and provide further insights into the
understanding of the consequences of cell therapy.
Materials and methods
Animals and reagents
Neonatal (0–1 d old) and adult Wistar rats (8 wk old) were purchased
from Takasugi Experimental Animals Supply, Co., Ltd. Adult GFP trans-
genic mice (Okabe et al., 1997) were gifts from Dr. Okabe (Osaka Uni-
versity, Osaka, Japan). Neonatal and adult GFP transgenic rats (Ito et al.,
2001) were purchased from Japan SLC. All protocols were approved by
the Institutional Animal Care and Use Committee of Chiba University. The
following antibodies were used for immunostaining: mouse monoclonal
anti-cTnT (RV-C2, DSMZ-Deutsche Sammlung von Mikroorganismen und
Zellkulturen GmbH), goat polyclonal anti-cTnT, goat polyclonal anti-
GATA4 (Santa Cruz Biotechnology, Inc.), rabbit polyclonal anti-ANF (Pen-
insula Laboratories), rabbit polyclonal anti-connexin43 (Zymed Laborato-
ries), rabbit polyclonal anti-desmin, rabbit polyclonal anti-vWF, mouse
monoclonal anti–rat Ki67, mouse monoclonal anti–human Ki67 (Dako
Cytomation), mouse monoclonal anti- -gal, rabbit polyclonal anti- -gal
(CHEMICON International, Inc.), mouse monoclonal anti-vimentin, mouse
monoclonal anti-Cre (Sigma-Aldrich), rabbit polyclonal anti-PH3 (Upstate
Biotechnology), mouse monoclonal anti-cyclinB1 (Neomarkers), and rabbit
polyclonal anti-RFP (MBL International Corporation). Fluorescent secondary
antibodies were purchased from Jackson ImmunoResearch Laboratories.
pLEGFP-N1 and pDsRed2-N1 were purchased from CLONTECH Laborato-
ries. Other reagents not specified were obtained from Sigma-Aldrich.
Cell culture
Neonatal rat cardiomyocytes and neonatal mouse cardiomyocytes were
cultured as described previously (Komuro et al., 1990), basically accord-
ing to the methods of Simpson and Savion (1982). Cardiomyocytes were
plated at a field density of 10
5 cells/cm
2 on 35-mm culture dishes contain-
ing cover glasses coated by 1% gelatin, and cultured in DME with 10%
FBS. cFB were obtained from primary culture described above by preplat-
ing technique. Fibroblasts on culture dishes were diluted fourfold, and in-
fected with GFP- or RFP-expressing retroviral vector. Identification and
characterization of GFP
  or RFP
  cFB was accomplished by immunocy-
tochemistry and there were not vWF- and cTnT-expressing cells in GFP
  or
RFP
  cFB. cFB from passages 3–5 were used. HUVEC were cultured on
0.1% gelatin-coated 100-mm dishes with EGM-2 (Cambrex Bio Science).
Bone marrow mononuclear cells were isolated from 10-wk-old GFP
mouse by density gradient centrifugation with Histopaque-1083 as de-
scribed previously (Zou et al., 2003). Primary culture of the bone marrow
cells was performed according to Dexter’s method with a few modifications
(Dexter et al., 1977). Cells were cultured in Iscove’s modified Dulbecco’s
medium supplemented with 10% FBS at 33 C in humid air with 5% CO2.
After 4 d in culture, nonadherent cells were collected as hematopoietic
cells and were used to coculture with cardiomyocytes. Adherent cells were
cultured though 14 d and were used to coculture with cardiomyocytes.
Human peripheral mononuclear cells were isolated from blood of hu-
man healthy volunteers by density gradient centrifugation with Histopaque-
1077. Cells were plated on culture dishes coated with fibronectin in 0.5%
gelatin solution and maintained in EGM-2. After 4 d in culture, nonadherent
cells were removed by washing with PBS, and the culture was maintained
though 7 d. After 7 d in culture, EPCs, recognized as attaching spindle-
shaped cells, were assayed by costaining with DiI-labeled AcLDL (Biomedi-
cal Technologies) and FITC-labeled UEA-1 lectin. Cells were first incubated
with 10 mg/ml DiI-labeled AcLDL at 37 C for 1 h and later fixed with 2%
PFA for 10 min. After washes, the cells were reacted with 10 mg/ml FITC-
labeled UEA-1 for 1 h. At 7 d in culture,  30% of cells expressed vWF. Ad-
herent cells at 7 d in culture were used to coculture with cardiomyocytes.
Skeletal muscle–derived cells were isolated from hind limbs of neo-
natal Sprague-Dawley rats or adult mice as described previously (Iijima et
al., 2003). In brief, muscle tissues were minced smaller than 1 mm
3 and
digested for a total of 45–60 min of three successive treatments with
0.05% trypsin-EDTA. The cells were collected in the supernatant after each
treatment and resuspended in Ham’s F10 medium in the presence of 20%
horse serum, 0.5% chicken embryo extract, and 2.5 ng/ml bFGF. The
cells were grown for 4 d in the same medium on the 2% gelatin-coated
dishes. Then the medium was replaced by fresh medium supplemented
with 20% FBS and cultured for 2 d.
Labeling of cells
DsRed2 sites of pDsRed2-N1 were subcloned in frame into Xho1 and
Not1 sites of pLEGFP-N1 vector. Retroviral stocks were generated as de-
scribed previously (Minamino et al., 2001). HUVEC and cFB were in-
fected with the GFP- or RFP-expressing retroviral vector. Infected cells were
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efficiency of transfection of GFP and RFP was over 95%. Skeletal muscle–
derived cells at 4 d after isolation were infected with RFP-expressing retro-
viral vector. Infected cells were not selected and used for transplantation.
The efficiency of transfection of RFP was  50%.
Neonatal rat cardiomyocytes and neonatal mouse cardiomyocytes
were tagged with recombinant adenovirus containing the Escherichia coli
LacZ gene at a multiplicity of infection of 20 units for 24 h before cocul-
ture. After X-gal staining (Minamino et al., 2002),  100% of cardiomyo-
cytes were recognized to express  -gal.
The adenovirus AxCANCre (RIKEN BRC DNA Bank no. 1748) con-
tains the Cre gene with a nuclear localized signal (NCre) (Kanegae et al.,
1995) driven by the CAG promoter (Niwa et al., 1991). HUVEC were in-
fected with AxCANCre at a multiplicity of infection of 50 units for 24 h be-
fore the transplantation. After immunostaining,  100% of HUVEC were
recognized to express Cre.
Coculture of neonatal cardiomyocytes with noncardiomyocytes
Neonatal cardiomyocytes were cultured through 4 d and then fluores-
cence-labeled HUVEC, cFB, bone marrow cells, and nonlabeled EPCs
were cultured with cardiomyocytes at a 1:4 ratio. Coculture was main-
tained in adequate medium for each noncardiomyocyte. Cells were fixed
with 4% PFA for 15 min at RT and were subjected to immunostaining at
various time points after starting coculture.
Cell transplantation
GFP transgenic adult male rats were anesthetized with ketamine (50 mg/
kg, i.p.) and xyladine (10 mg/kg, i.p.). A normal heart was injected with
a standard dose of 10
6 RFP-expressing HUVEC or skeletal muscle–derived
cells (Reinecke and Murry, 2003). In the HUVEC transplantation model,
the immunosupressor FK506 (Fujisawa Pharmaceutical) was administered
i.p. at 2.0 mg/kg body weight on the day of injection and maintained un-
til the animals were killed. The hearts were fixed according to the perio-
date–lysine–PFA fixative methods and were snap-frozen in nitrogen and
stored for subsequent immunohistochemical analysis.
MerCreMer mice express MerCreMer fusion protein driven by the
 MHC promoter (Sohal et al., 2001). CAG-CAT-LacZ transgenic mice di-
rect expression of the E. coli LacZ gene upon Cre-mediated excision of the
loxP-flanked CAT gene located between the CAG promoter and the LacZ
gene (Sakai and Miyazaki, 1997; Dr. Miyazaki, Osaka University, Osaka,
Japan). A dose of 10
6 Cre-expressing HUVEC were transplanted to the
heart of CAG-CAT-LacZ transgenic mice with the i.p. administration of
FK506 at 2.0 mg/kg body weight on the day of injection and maintained
until the animals were killed. A dose of 10
6 skeletal muscle–derived cells
isolated from CAG-CAT-LacZ transgenic mice were transplanted to the
heart of MerCreMer mice. MerCreMer mice were treated with tamoxifen
(20 mg/kg/day, i.p.) 7 d before transplantation and the treatment was
maintained until 2 d before the transplantation. At 4 d after transplanta-
tion, mice were killed and the hearts were perfused with 2% PFA and
were snap-frozen in nitrogen. A couple of adjacent sections as a mirror
image were prepared and fixed with 0.25% glutaraldehyde or 2% PFA
for 15 min and were analyzed by X-gal staining or immunohistochemistry.
Cryoinjury
Male Wistar rats were anesthetized with ketamine (50 mg/kg, i.p.) and
xyladine (10 mg/kg, i.p.) and a 6-mm aluminum rod, cooled to  190 C
by immersion in liquid nitrogen applied to the left ventricular free wall to
produce cryoinjury. The rats were killed at 4 d after cryoinjury. The
hearts were snap-frozen in nitrogen. A couple of adjacent sections as a
mirror image were prepared and fixed with 4% PFA and were subjected
to immunostaining.
Immunohistochemistry
Fixed cells were preblocked with PBS containing 2% donkey serum, 2%
BSA, and 0.2% NP-40 for 30 min. Primary antibodies were diluted with
PBS containing 2% donkey serum, 2% BSA, and 0.1% NP-40 and applied
over night at 4 C. FITC-, Cy3-, or Cy5-conjugated secondary antibodies
were applied to visualize expression of specific proteins. Before mounting,
nuclei were stained with Hoechst 33258 (1  g/ml) or Topro3 (Molecular
Probes, Inc.). Images of samples were taken by laser confocal microscopy
(Radiance 2000; Bio-Rad Laboratories) or with a fluorescent microscope
(Carl Zeiss MicroImaging, Inc.) equipped with a CCD camera (Axiocam;
Carl Zeiss MicroImaging, Inc.).
Nocodazole treatment and cell cycle analysis
Neonatal rat cardiomyocytes fused with GFP
  HUVEC or GFP
  cFB were
treated with 50 ng/ml nocodazole for 6–24 h and at each time cells were
fixed and stained with anti-cTnT and anti-PH3 antibodies. Some of the
cells treated with nocodazole for 6 h cocultured with HUVEC and for 24 h
cocultured with cFB were released from nocodazole and cultured further
for 3 h and fixed.
Statistical analysis
Values are presented as mean   SD. The significance of differences
among mean values was determined by one-factor ANOVA, chi-square in-
dependent test, and Kruskal-Wallis test. Probability (P) values were cor-
rected for multiple comparisons by the Bonferroni correction. The accepted
level of significance was P   0.05.
Online supplemental material
Live images of beating cells were obtained with an inverted microscope
(Carl Zeiss MicroImaging, Inc.) equipped with a chilled CCD camera
(Hamamatsu Corporation) using I-O DATA Videorecorder software. On-
line supplemental material available at http://www.jcb.org/cgi/content/
full/jcb.200312111/DC1.
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